The authors summarize their own experiences on 20 patients with immunotherapy against atopic dermatitis. The efficacy of the therapy, the beginning of the effect and the need for concomitant therapy were evaluated. The results were similar to those published in the literature. The allergens were diagnosed in each case in vivo by the intradermal skin test. 70% of the owners were satisfied with the effect of the hyposensibilisation. Symptoms were reduced by a minimum of 50% in 11 cases (55%) (Figure 7). In 70% of the cases concomitant therapies were needed. The half of the patients began to react to therapy between the 3rd to 6th months of the treatment. There were two peaks of the beginning of effect: on the 6th and the 16th week 20-20% of the atopic dogs began to react, respectively (Figure 2). There was large difference between the average time of existence of the symptoms before therapy between the patients who reacted well (9.2 months) and the patients who reacted poorly (19.5 months) to the hyposensibilisation (Figure 3). That is why the early diagnosis and treatment is recommended in the immunotherapy. The four patients who have been treated for 4 years didn't show any side effect during the time of the survey.
|Number of pages||8|
|Journal||Magyar Allatorvosok Lapja|
|Publication status||Published - Sep 2004|
ASJC Scopus subject areas